Effect of Ferrous and Vitamin E on Rabbit Serum Lipoproteins

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor, Department of Cardiovascular, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Associate Professor, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Epidemiology & Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran

5 Medical Student, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Fatty streaks are the primary lesions to form atherosclerosis. Lipid per oxidation by free- radicals, plays an important role in plaque formation. Vitamin E, as a lipid in soluble vitamin, is an important antioxidant and may prevent or delay the coronary heart disease by limiting LDL oxidation. Our goal was to evaluate the effect of vitamin E and iron on blood serum lipids in male rabbits fed high-cholestrol diet.Method: Thirty white male rabbits were weighed and blood serum samples were taken for analysis of serum lipoproteins. They were randomly divided in to 5 groups each Containing 6 rabbits for 42 days. Group1 was given normal diet. Group 2 fed with high cholesterol (2 %) diet. Group 3 fed with high cholesterol diet with iron (50 mg/kg). Group 4 fed with high cholesterol diet with vitamin E (50 mg/kg). Group 5 fed with high cholesterol diet with iron (50 mg/kg) and vitamin E (50 mg/kg). These groups were again weighed and blood samples were taken for analysis of serum lipoproteins after 42 days.Results: Significant difference in cholesterol, LDL, HDL, TG, and VLDL were seen before and after the experiment in all 5 groups (P < 0.001).Conclusion: The significant difference was observed between all groups in relation to the effect of iron and vitamin E on lipid metabolism. While vitamin E has a protective role in atherosclerosis, it seems that iron has a provocation role in serum lipids.

Keywords


  1. Gerrity RG, Antoniv AS. The pathogenesis of atherosclerosis. Diabetolog ia1997;40: 108110.
  2. Glass Ck, Wittum JL. The road a head of call. Atherosclerosis 2001;104:503.
  3. Libby P et al: Inflammation and Atherosclerosis . Circulation 2002;105:11- 32.
  4. Hansson G, Libby P: The role of the lymphocyte in fuster V,Rose R, topol E (eds):Atherosclerosis and coronary artery disease. Vol 1.New York Lippincott - Raven, 1996.
  5. Devies Mj, woolfN, Rowles PM, Pepper J. Morphology of endothelium over atherosclerosis plaques in human coronary arteries. Br Heart J 1988;60:459.
  6. Falk E, shah PK, Fuster V. Coronary plaque distruption. Circulation 1998;92:115-126.
  7. Leak DS, Rankin SM. The oxidative modifica-tion of low density Lipoproteins by macrophages. Bio Chem J 1990;270:741-748.
  8. Chalerjea SN.Clin chemistry , Jay pee publish-ers, medical publications, New Delhi, 1999.
  9. Martin A, Frei B. Both Intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cell.
  10. Porreca E, Ucchio S, Di Febbo G, Di Bartolome N, Angelucci D Napditano AM. Antiproliferative effect of desferrioxamine on vascular smooth muscle cells invitro and invivo. Biochem J1994;300:799-803.
  11. Traber MG and packer L. vitamin E: Beyond antioxidant function. Am J clin Nutr 1995;62:15015-95.
  12. Bender DA: Nutritional Biochemistre of Vita-mins , 2 nd edition. Cambridge university press. 2003.
  13. Jalal I and Fuller CJ. Effect of vitamin E, Vita-min C and beta-carotene on LDL oxidation and atherosclerosis. Can J cardiol 1995;11 suppl G: 976-1036.
  14. 14-Manttari M, Manninen V, Huttunen JK, Palosuo T, Ehnholm OP, Heinonen OP, et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 1994;15:1599-603.
  15. Singh RB, Niaz MA, Ghosh S, Agrawal P, Ah-mad S, Beegom R, Onouchi Z, Jummerow FA. Randomized, controlled trial of antioxidant vitamins and cardioprotective dier on hyperlipidemia, oxidative stress and development of experimental atherosclerosis: The Diet and Antioxidant Trial on Atherosclerosis. Cardiovasc Drug Ther 1995;9:763-771.
  16. Gerrity RG, Antoniv AS. The pathogenesis of atherosclerosis.
  17. Diabetolog ia , 1997;40: 108-110.
  18. Hoff HF. Apolipoprotein localization in hu-man cranial arteries coronary arteries and the aorta. Stroke 1967;7 (4):390-393.
  19. Hansson G, Libby P: The role of the lymphocyte in fuster V, Rose R, topol E (eds): Atherosclerosis and coronary artery disease. Vol 1.New York Lippincott - Raven, 1996.
  20. Emeson EE, Robertson AL Jr: T Lymphocytes in aortic and coronary in timas. Am J pathol 1988;130:169-376.
  21. Devies MJ, WoolfN,Rowles PM, Pepper J. Morphology of endothelium over ath-erosclerosis plaques in human coronary arteries. Br Heart J 1988; 60:459.